Skip to main content

David Fox

Interests include small molecule (asymmetic) synthesis and applications of these molecules, mainly in medicinal chemistry but also materials. Nowadays ideas and projects involve synthesis as well as calculation of molecular properties, reaction mechanism and IR / NMR / CD spectra by DFT, as well as numerical data analysis for complex catalysis kinetics.

Specialist areas include fast and direct synthesis, medicinal chemistry, and ideal scale up methods for lead molecules.

As well as an academic role at Warwick, Fox was lead chemist at Funxional Therapeutics (2006-12), is currently Head of Chemistry at Epsilon3Bio, and consultant at RxChemistry (part of RxCelerate Ltd).